| Literature DB >> 21375718 |
Ida Rud1, Kristine Naterstad, Roger S Bongers, Douwe Molenaar, Michiel Kleerebezem, Lars Axelsson.
Abstract
The level of the central glycolytic gene regulator (CggR) was engineered in Lactobacillus plantarum NC8 and WCFS1 by overexpression and in-frame mutation of the cggR gene in order to evaluate its regulatory role on the glycolytic gap operon and the glycolytic flux. The repressor role of CggR on the gap operon was indicated through identification of a putative CggR operator and transcriptome analysis, which coincided with decreased growth rate and glycolytic flux when cggR was overexpressed in NC8 and WCFS1. The mutation of cggR did not affect regulation of the gap operon, indicating a more prominent regulatory role of CggR on the gap operon under other conditions than tested (e.g. fermentation of other sugars than glucose or ribose) and when the level of the putative effector molecule FBP is reduced. Interestingly, the mutation of cggR had several effects in NC8, i.e. increased growth rate and glycolytic flux and regulation of genes with functions associated with glycerol and pyruvate metabolism; however, no effects were observed in WCFS1. The affected genes in NC8 are presumably regulated by CcpA, since putative CRE sites were identified in their upstream regions. The interconnection with CggR and CcpA-mediated control on growth and metabolism needs to be further elucidated.Entities:
Mesh:
Substances:
Year: 2010 PMID: 21375718 PMCID: PMC3818993 DOI: 10.1111/j.1751-7915.2010.00223.x
Source DB: PubMed Journal: Microb Biotechnol ISSN: 1751-7915 Impact factor: 5.813
Figure 1Comparison between L. plantarum and B. subtilis in relation to gap operon and putative regulation sites upstream the cggR gene. A. Organization of the gap operon (Ludwig ; Naterstad ). Promoters and rho‐independent terminator structures are indicated by small arrows and loops respectively. CggR operators are shown as black boxes. Processing site of cggR in B. subtilis is indicated by a scissor. B. Promoter prediction of the cggR gene in L. plantarum compared with B. subtilis (Ludwig ). Consensus sequences (−35 and −10) and TG motifs are underlined. Distances to the atg start of cggR are indicated. C. Comparison of the putative CggR operator of L. plantarum with the CggR operator of B. subtilis (Doan and Aymerich, 2003). Direct repeats in L. plantarum are underlined. Distances between the repeats and distances to the atg start of cggR are indicated.
Growth rate and metabolic fluxes of cggR‐engineered strains of L. plantarum NC8 and WCFS1 during glucose or ribose fermentation.
| Carbon source | Strain | Growth rate (h−1/% relative to wild type) | Glycolytic flux (mmol*h−1*gdw/% relative to wild type) | Lactate flux (mmol*h−1*gdw/% relative to wild type) | |||
|---|---|---|---|---|---|---|---|
| NC8 | WCFS1 | NC8 | WCFS1 | NC8 | WCFS1 | ||
| Glucose | Wild type | 0.48/100 ± 0 | 0.53/100 ± 0 | 9.6/100 ± 5 | 10.1/100 | 18.6/100 ± 1 | 19.6/100 |
| 0.52/109 ± 1 | 0.52/98 ± 0 | 11.3/118 ± 4 | 9.6/95 | 21.1/113 ± 2 | 18.7/95 | ||
| 0.36/76 ± 10 | 0.41/77 ± 2 | 6.9/72 ± 14 | 7.4/74 | 11.7/63 ± 4 | 14.4/73 | ||
| Ribose | Wild type | 0.31/100 ± 0 | 0.32/100 ± 0 | ND | ND | ND | ND |
| 0.32/105 ± 2 | 0.31/97 ± 1 | ND | ND | ND | ND | ||
| 0.24/79 ± 3 | 0.25/77 ± 1 | ND | ND | ND | ND | ||
Standard deviations of duplicate cultures are included, except for metabolic fluxes of WCFS1 where only one culture was measured on HPLC. However, the collected samples from WCFS1 were measured twice on the HPLC, showing statistically the same results.
ND, not determined.
Genes with significant CE, ME or IE in L. plantarum NC8.
| Gene locus | Gene | Product | CE | ME | IE |
|---|---|---|---|---|---|
| Amino acid biosynthesis | |||||
| lp_1375 | 5‐Methyltetrahydropteroyltriglutamate – homocysteine | 0.5 | |||
| lp_2685 | Dihydrodipicolinate synthase | 0.8 | |||
| Biosynthesis of cofactors, prosthetic groups and carriers | |||||
| lp_2612 | Pyrazinamidase/nicotinamidase | −0.6 | |||
| Cell envelope | |||||
| lp_1070 | Lipoprotein precursor | 0.7 | |||
| lp_3679 | Extracellular protein | 0.5 | |||
| Cellular processes | |||||
| lp_0409 | Immunity protein PlnM | 2.6 | |||
| lp_0412 | Immunity protein PlnP, membrane‐bound protease CAAX family | 2.2 | |||
| lp_2544 | NADH peroxidase | 0.6 | |||
| lp_2906 | DNA‐entry nuclease | −0.9 | −1.0 | ||
| lp_3128 | Stress induced DNA‐binding protein | −0.6 | |||
| Central intermediary metabolism | |||||
| lp_0193 | Alpha‐glucosidase | 2.6 | 1.0 | ||
| DNA metabolism | |||||
| lp_0432 | DNA helicase (putative) | −0.6 | |||
| lp_0772 | Excinuclease ABC, subunit B | −0.7 | −0.6 | ||
| lp_0773 | Excinuclease ABC, subunit A | −0.8 | |||
| lp_2280 | DNA‐damage‐inducible protein P | −0.9 | −1.2 | ||
| lp_2301 | Recombinase A | −0.8 | −0.7 | ||
| lp_2693 | ATP‐dependent nuclease, subunit A | −0.8 | −0.7 | ||
| lp_2694 | ATP‐dependent nuclease, subunit B | −0.7 | |||
| lp_3023 | UV‐damage repair protein | −1.5 | −1.6 | ||
| Energy metabolism | |||||
| lp_0329 | Acetaldehyde dehydrogenase | −3.3 | |||
| lp_0852 | Pyruvate oxidase | 2.3 | |||
| lp_1112 | Fumarate hydratase | −0.8 | |||
| lp_2151 | Pyruvate dehydrogenase complex, E3 component | 2.8 | |||
| lp_2152 | Pyruvate dehydrogenase complex, E2 component | 3.0 | |||
| lp_2153 | Pyruvate dehydrogenase complex, E1 component, beta subunit | 3.7 | 1.0 | ||
| lp_2154 | Pyruvate dehydrogenase complex, E1 component, alpha subunit | 4.1 | −0.9 | 1.1 | |
| lp_2629 | Pyruvate oxidase | 2.5 | 1.5 | ||
| lp_3045 | Short‐chain dehydrogenase/oxidoreductase | −0.5 | |||
| lp_3313 | Formate C‐acetyltransferase | 3.1 | 1.2 | ||
| lp_3314 | Formate acetyltransferase‐activating enzyme | 2.7 | 0.9 | ||
| lp_3418 | Phosphoenolpyruvate carboxykinase (ATP) | 2.5 | 0.9 | ||
| lp_3420 | Glutamate decarboxylase | −0.5 | |||
| lp_3483 | Beta‐galactosidase, large subunit | 2.3 | |||
| lp_3484 | Beta‐galactosidase, small subunit | 2.0 | |||
| lp_3487 | Aldose 1‐epimerase | 2.8 | 0.6 | ||
| lp_3525 | 6‐Phospho‐beta‐glucosidase | 2.1 | |||
| lp_3538 | Transketolase | 6.5 | 0.8 | ||
| lp_3539 | Transaldolase | 6.5 | |||
| lp_3589 | Pyruvate oxidase | 2.3 | 0.7 | ||
| Fatty acid and phospholipid metabolism | |||||
| lp_0168 | Dihydroxyacetone kinase | 0.7 | |||
| lp_0169 | Dihydroxyacetone phosphotransferase, dihydroxyacetone binding subunit | 0.8 | |||
| lp_0371 | Glycerol‐3‐phosphate dehydrogenase | 4.0 | 2.5 | ||
| Purines, pyrimidines, nucleosides and nucleotides | |||||
| lp_0242 | Nucleoside‐diphosphate kinase | 3.9 | 1.2 | ||
| lp_0692 | Ribonucleoside‐diphosphate reductase, beta chain | −0.6 | −0.5 | ||
| lp_0693 | Ribonucleoside‐diphosphate reductase, alpha chain | −0.6 | |||
| lp_2697 | Orotate phosphoribosyltransferase | −1.0 | |||
| lp_2702 | Dihydroorotase | −0.5 | |||
| lp_2931 | Anaerobic ribonucleotide reductase activator protein | −1.1 | −1.1 | ||
| lp_2932 | Anaerobic ribonucleoside‐triphosphate reductase | −1.0 | −0.8 | ||
| lp_3271 | GMP reductase | −0.5 | |||
| Regulatory functions | |||||
| lp_0788 | Central glycolytic gene regulator | 2.8 | |||
| lp_0889 | Transcription regulator | 0.6 | 0.5 | ||
| lp_2964 | Transcription regulator (putative) | −0.5 | |||
| lp_3345 | Regulatory protein Spx | 0.8 | |||
| lp_3655 | Sorbitol operon activator | 0.8 | |||
| Transport and binding protein | |||||
| lp_0171 | Dihydroxyacetone transport protein (putative) | 0.7 | |||
| lp_0349 | Ammonium transport protein | −2.8 | |||
| lp_0372 | Glycerol uptake facilitator protein | 3.1 | 1.8 | ||
| lp_0436 | Cellobiose PTS, EIIC | 0.6 | |||
| lp_0439 | Cellobiose PTS, EIIC | 0.9 | |||
| lp_0575 | Mannose PTS, EIIAB | −2.4 | 0.6 | ||
| lp_0576 | Mannose PTS, EIIC | −2.6 | 0.6 | 0.6 | |
| lp_0749 | Phosphate ABC transporter, ATP‐binding protein | −2.1 | |||
| lp_0770 | Multidrug transport protein | −0.7 | |||
| lp_1120 | Amino acid transport protein | −2.0 | |||
| lp_1945 | ABC transporter, ATP‐binding protein | 2.8 | |||
| lp_2509 | Transport protein | −2.2 | |||
| lp_2780 | Cellobiose PTS, EIIA | 2.9 | −0.6 | 0.6 | |
| lp_3008 | Cellobiose PTS, EIIA | 2.1 | |||
| lp_3278 | Amino acid transport protein | −2.1 | |||
| lp_3279 | Potassium uptake protein | −0.6 | −0.5 | ||
| lp_3303 | Multidrug transport protein | 0.6 | |||
| lp_3540 | Transport protein | 6.5 | 0.6 | ||
| lp_3541 | PTS, EIIB | 6.5 | |||
| lp_3547 | Galactitol PTS, EIIB | 0.6 | |||
| lp_3658 | Ribose transport protein | 6.7 | |||
| lp_3659 | Ribose transport protein, membrane‐associated protein | 7.1 | |||
| Hypothetical proteins | |||||
| lp_0058 | Unknown | 2.7 | |||
| lp_0063 | Unknown | 2.2 | |||
| lp_0089 | Unknown | −0.6 | |||
| lp_0137 | Oxidoreductase | −0.7 | |||
| lp_0170 | Dihydroxyacetone phosphotransferase, phosphoryl donor protein | 0.9 | |||
| lp_0214 | Integral membrane protein | −2.2 | |||
| lp_0240 | Unknown | 3.6 | −0.5 | 1.0 | |
| lp_0402 | Unknown | −0.5 | |||
| lp_0691 | Unknown | −0.8 | −0.6 | ||
| lp_0960 | Unknown | −1.4 | −1.2 | ||
| lp_1068 | Unknown | 0.5 | |||
| lp_1611 | Unknown | −1.2 | −1.1 | ||
| lp_1908 | Integral membrane protein | −0.8 | |||
| lp_2732 | Oxidoreductase | 0.5 | |||
| lp_2813 | Unknown | 2.2 | |||
| lp_2948 | Unknown | 0.8 | |||
| lp_3022 | Unknown | −1.4 | −1.6 | ||
| lp_3078 | Hydrolase, HAD superfamily | 2.3 | 0.5 | ||
| lp_3142 | Unknown | −1.1 | −1.1 | ||
| lp_3318 | Oxidoreductase | 2.5 | |||
| lp_3537 | Hydrolase, HAD superfamily, Cof family | 6.3 | |||
| Other categories | |||||
| lp_0655 | Prophage P1 protein 32 | −0.7 | −0.6 | ||
| lp_2442 | Prophage P2a protein 15 | 2.6 | |||
Log2‐value based on spot intensity of one probe.
Log2‐value based on spot intensities of the two cggR probes that were not in the deleted region of cggR (FDR < 0.001).
CE (carbon source effect), log2 of > 2.0 or < −2.0.
ME (mutation effect), log2 of > 0.5 or < −0.5.
IE (interaction effect), log2 of > 0.5 or < −0.5.
Figure 2Schematic representation of the metabolic pathways for glucose and ribose fermentation in L. plantarum, including significant IE genes in NC8. The IE genes are divided into the individual MEs on ribose (grey symbols) and glucose (black symbols) respectively. Upward‐pointing triangles indicate upregulated genes, downward‐pointing triangles indicate downregulated genes and boxes indicate none‐regulated genes. The functions of the genes are described in Table 2.
Figure 3Genes and operons identified with a putative CRE site upstream to the (first) gene. Only genes of NC8 with significant IE, and with functions predicted to energy metabolism, fatty acid and phospholipid metabolism are included. The identification is based on the genome sequence of WCFS1. Position of the CRE boxes relative to the start of the gene is indicated. Asterisk indicates a previous identified CRE box (Lorquet ) with three base mismatches. The functions of the genes are described in Table 2.